We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drug repositioning: a brief overview.
- Authors
Jourdan, Jean-Pierre; Bureau, Ronan; Rochais, Christophe; Dallemagne, Patrick
- Abstract
Objectives Drug repositioning, that is, the use of a drug in an indication other than the one for which it was initially marketed, is a growing trend. Its origins lie mainly in the attrition experienced in recent years in the field of new drug discovery. Key findings Despite some regulatory and economic challenges, drug repositioning offers many advantages, and a number of recent successes have confirmed both its public health benefits and its commercial value. The first examples of successful drug repositioning mainly came about through serendipity like acetylsalicylic acid, thalidomide, sildenafil or dimethylfumarate. Conclusion The history of great-repositioned drugs has given some solutions to various pathologies. Serendipity is not yet useful to find repositioning drugs. Drug repositioning is of growing interest. Nowadays, a more rational approach to the identification of drug candidates for repositioning is possible, especially using data mining.
- Subjects
DRUG repositioning; ASPIRIN; DRUG utilization; DATA mining; SILDENAFIL
- Publication
Journal of Pharmacy & Pharmacology, 2021, Vol 73, Issue 11, p1145
- ISSN
0022-3573
- Publication type
Article
- DOI
10.1111/jphp.13273